Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease

Scandinavian Journal of Gastroenterology

Volumn 51, Issue 7, 2016, Pages 848-854

  Vegh, Zsuzsanna ^a,b   Kurti, Zsuzsanna ^a   Gonczi, Lorant ^a   Golovics, Petra Anna ^a   Lovasz, Barbara Dorottya ^a   Szita, Istvan ^b   Balogh, Mihaly ^c   Pandur, Tunde ^b   Vavricka, Stephan R ^d   Rogler, Gerhard ^d   Lakatos, Laszlo ^b   Lakatos, Peter Laszlo ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Csolnoky Hospital   (Hungary)

^c Grof Eszterhazy Hospital   (Hungary)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Anaemia; disease outcome; extraintestinal manifestations; inflammatory bowel disease

Indexed keywords

AZATHIOPRINE; STEROID;

ADULT; ANEMIA; ARTICLE; COLON RESECTION; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HOSPITALIZATION; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ULCERATIVE COLITIS; COMPLICATION; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADULT; ANEMIA; AZATHIOPRINE; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STEROIDS; YOUNG ADULT;

EID: 84958559602     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2016.1140807     Document Type: Article

References (19)

1. C.N.Bernstein, J.F.Blanchard, P.Rawsthorne,. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96:1116–1122.
2. F.T.Veloso, J.Carvalho, F.Magro Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol. 1996;23:29–34.
3. S.R.Vavricka, L.Brun, P.Ballabeni,. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110–119.
4. S.R.Vavricka, G.Rogler, C.Gantenbein,. Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss inflammatory bowel disease cohort. Inflamm Bowel Dis. 2015;21:1794–1800.
5. L.Lakatos, T.Pandur, G.David,. Association of extraintestinal manifestations of inflammatory bowel disease in a province of Western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol. 2003;9:2300–2307.
6. A.J.Greenstein, H.D.Janowitz, D.B.Sachar The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine. 1976;55:401–412.
7. C.B.Lamers Treatment of extraintestinal complications of ulcerative colitis. Eur J Gastroenterol Hepatol. 1997;9:850–853.
8. T.Ljung, M.Staun, O.Grove,. Pyoderma gangrenosum associated with Crohn disease: effect of TNF-alpha blockade with infliximab. Scand J Gastroenterol. 2002;37:1108–1110.
9. N.Filmann, J.Rey, S.Schneeweiss,. Prevalence of anaemia in inflammatory bowel diseases in European countries: a systematic review and individual patient data meta-analysis. Inflamm Bowel Dis. 2014;20:936–945.
10. I.E.Koutroubakis, C.Ramos-Rivers, M.Regueiro,. Persistent or recurrent anaemia is associated with severe and disabling inflammatory bowel disease. Clin Gastroenterol Hepatol. 2015;13:1760–1766.
11. J.E.Lennard-Jones Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989;24:2–6.
12. J.Satsangi, M.S.Silverberg, S.Vermeire,. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753.
13. L.Lakatos, L.S.Kiss, G.David,. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflamm Bowel Dis. 2011;17:2558–2556.
14. P.L.Lakatos, P.A.Golovics, G.David,. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977–2009. Am J Gastroenterol. 2012;107:579–588.
15. World Health Organization. Iron deficiency anaemia assessment, prevention and control a guide for programme managers. Report; 2011. Report No.: WHO/NHP/01.3.
16. R.Isene, T.Bernklev, O.Høie,. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scand J Gastroenterol. 2015;50:300–305.
17. M.L.Høivik, W.Reinisch, M.Cvancarova, et al. IBSEN study group. Anaemia in inflammatory bowel disease: a population-based 10-year follow-up. Aliment Pharmacol Ther. 2014 Jan;39:69–76.
18. D.Sjöberg, T.Holmström, M.Larsson,. Anaemia in a population-based IBD cohort (ICURE): still high prevalence after 1 year, especially among pediatric patients. Inflamm Bowel Dis. 2014;20:2266–2270.
19. M.Voegtlin, S.R.Vavricka, A.M.Schoepfer,. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals. J Crohns Colitis. 2010;4:642–648.